Evidence map›Paper›PMID 39932526›Full record

ArticleObesity surgery2025

How Long Can an Intragastric Balloon Remain in the Stomach Safely? A Rare Case Report on 5.5 Years of Asymptomatic Retention.

Mehmet Gencturk, Muhammed Said Dalkılıç, Hasan Erdem, Abdullah Sisik

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advances and future directions in endoscopic bariatric therapies.World journal of gastrointestinal endoscopy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mehmet GencturkDr HE Obesity Clinic, Istanbul, Turkey.
Muhammed Said DalkılıçDepartment of General Surgery, School of Medicine, Marmara University, Istanbul, Turkey. saiddalkilic@hotmail.com.
Hasan ErdemDr HE Obesity Clinic, Istanbul, Turkey.
Abdullah SisikDr HE Obesity Clinic, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intragastric balloons (IGBs) are widely used as a minimally invasive weight loss intervention for patients with obesity. While the recommended implantation period for most IGBs is 6 to 12 months, exceeding this duration is associated with an increased risk of complications such as deflation, migration, obstruction, and gastric perforation. However, the long-term safety of retained IGBs remains inadequately studied. We report a rare case of an asymptomatic 5.5-year retention of a Spatz3 IGB in a 29-year-old male patient. Initially implanted for obesity management with a body mass index (BMI) of 38 kg/m

Indexed as

Gastric BalloonObesity, MorbidStomachAdultDevice RemovalHumansMaleTime FactorsWeight LossBariatric endoscopyEndoscopic removalIntragastric balloonObesity managementProlonged retention

Identifiers

PMID39932526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.